Express News | Boston Scientific Corp- Sees Q2 EPS on a Gaap Basis in a Range of $0.35 to $0.37 and Adjusted EPS, of $0.57 to $0.59
Moomoo 24/7Apr 24 06:36 ET
Express News | Boston Scientific Corp- Sees Net Sales Growth for FY 2024, to Be in Range of Approximately 11 to 13 Percent on a Reported Basis
Moomoo 24/7Apr 24 06:33 ET
Express News | Boston Scientific Corp- Sees FY Adjusted EPS, Excluding Certain Charges (Credits), of $2.29 to $2.34
Moomoo 24/7Apr 24 06:32 ET
Express News | Boston Scientific Corp- Sees FY EPS on a Gaap Basis in a Range of $1.43 to $1.48
Moomoo 24/7Apr 24 06:32 ET
Press Release: Boston Scientific Announces Results for First Quarter 2024
Boston Scientific Announces Results for First Quarter 2024 PR Newswire MARLBOROUGH, Mass., April 24, 2024 MARLBOROUGH, Mass., April 24, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX
Dow JonesApr 24 06:30 ET
Wells Fargo Sticks to Its Hold Rating for Axonics Modulation Technologies (AXNX)
TipRanksApr 23 09:38 ET
RBC Capital Remains a Hold on Axonics Modulation Technologies (AXNX)
TipRanksApr 17 04:00 ET
Express News | Axonics Shares Are Trading Lower After the Company and Boston Scientific Receive a Request for Additional Information From the FTC in Connection With the FTC's Review of the Merger Agreement. The Merger Is Now Expected to Be Completed in the Second Half o
Moomoo 24/7Apr 4 08:57 ET
Express News | Boston Scientific Earlier Disclosed That On Apr. 3, Co. And Axonics Received Request For Additional Information From FTC In Connection With FTC's Merger Review; Says The Merger Is Now Expected To Be Completed In The Second Half Of 2024
Moomoo 24/7Apr 4 08:55 ET
UPDATE 1-FTC Seeks More Information on Boston Scientific's $3.7 Bln Axonics Deal
Yahoo FinanceApr 4 07:45 ET
Boston Scientific, Axonics Merger Prompts FTC to Request Additional Information
By Denny Jacob Boston Scientific and Axonics each received a request for additional information from the Federal Trade Commission regarding a previously agreed upon merger. The medical device manufa
WSJApr 4 07:45 ET
All You Need to Know About Axonics (AXNX) Rating Upgrade to Buy
Yahoo FinanceMar 29 12:00 ET
Press Release: Axonics Stockholders Approve Merger Agreement With Boston Scientific
Axonics Stockholders Approve Merger Agreement with Boston Scientific IRVINE, Calif.--(BUSINESS WIRE)--March 22, 2024-- Axonics, Inc. (Nasdaq: AXNX) announced that its stockholders have voted today t
Dow JonesMar 22 16:01 ET
Axonics Updates On Inter Partes Review Proceedings; Plans To Seek Review Of The PTAB's Finding That Remaining Claims Were Not Unpatentable
Today, the PTAB invalidated 10 of the 15 challenged claims in Medtronic's '314 patent and declined to invalidate the challenged claims in the '756 patent over one Administrative Patent Judge's dissent
BenzingaMar 21 16:58 ET
Axonics Provides Update on Inter Partes Review Proceedings
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has issued written decisions on two
BusinesswireMar 21 16:54 ET
Gastroenterology Group of Naples Introduces Innovative Axonics Sacral Neuromodulation Therapy
New Treatment Option Offers Long-Term Relief for Those Suffering from Gastrointestinal Disorders NAPLES, Fla., March 19, 2024 /PRNewswire/ -- Gastroenterology Group of Naples, a partner practice of U
PR NewswireMar 19 10:11 ET
Catalyst Watch: Fed Rates Meeting, Nvidia CEO Speaks at GTC 2024, Reddit IPO
Seeking AlphaMar 15 15:16 ET
Express News | Axonics Announced That The Axonics R20 Rechargeable Sacral Neuromodulation (Snm) System Has Received CE Mark Approval
Moomoo 24/7Mar 14 06:06 ET
Boston Scientific Pulls, Refiles HSR Notification for Axonics Deal
Seeking AlphaMar 8 10:34 ET
Axonics Ticks Higher as Boston Scientifc Reiterates Close in 1H24
Seeking AlphaMar 6 14:15 ET
No Data
No Data